Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Department of Internal Medicine

Division of Oncology

SCI/PUBMED listed | all typs of publications | all by year and first author | MUG authors |

** = Publications listed in SCI/SSCI/Pubmed

Full paper/article (Journal)

** Ay, C; Grilz, E; Nopp, S; Moik, F; Königsbrügge, O; Klimek, P; Thurner, S; Posch, F; Pabinger, I Atrial fibrillation and cancer: prevalence and relative risk from a nationwide study.
Res Pract Thromb Haemost. 2023; 7(1): 100026 Doi: 10.1016/j.rpth.2022.100026 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

** Beltran-Bless, AA; Clemons, MJ; Fesl, C; Greil, R; Pond, GR; Balic, M; Vandermeer, L; Bjelic-Radisic, V; Singer, CF; Steger, GG; Helfgott, R; Egle, D; Solkner, L; Gampenrieder, SP; Kacerovsky-Strobl, S; Suppan, C; Ritter, M; Rinnerthaler, G; Pfeiler, G; Fohler, H; Hlauschek, D; Hilton, J; Gnant, M Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
EUR J CANCER. 2023; 180: 108-116. Doi: 10.1016/j.ejca.2022.12.003
Web of Science PubMed FullText FullText_MUG

 

** Bögemann, M; Facchini, G; Bauernhofer, T; Cathomas, R; Xylinas, E; Tombal, B Role of apalutamide in the treatment landscape for patients with advanced prostate cancer: an expert opinion statement of European clinical practice.
Ir J Med Sci. 2023; Doi: 10.1007/s11845-023-03303-y
Web of Science PubMed FullText FullText_MUG

 

** Brcic, I; Kluba, AM; Godschachner, TM; Suppan, C; Regitnig, P; Dandachi, N; Lax, SF; Balić, M Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression.
Int J Mol Sci. 2023; 24(1): Doi: 10.3390/ijms24010818 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Egger, V; Hutterer, GC; Mischinger, J; Seles, M; Pichler, R; Mannweiler, S; Huber, K; Balihodzic, A; Spiegelberg, J; Bauernhofer, T; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery.
World J Urol. 2023; Doi: 10.1007/s00345-023-04379-y
Web of Science PubMed FullText FullText_MUG

 

** Fischer, S; Rothermundt, C; Stalder, O; Terbuch, A; Hermanns, T; Zihler, D; Müller, B; Fankhauser, CD; Hirschi-Blickenstorfer, A; Seifert, B; Kluth, LA; Ufe, MP; Mingrone, W; Templeton, AJ; Fischer, N; Rothschild, S; Woelky, R; Gillessen, S; Cathomas, R The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study.
Eur Urol Open Sci. 2023; 50:57-60 Doi: 10.1016/j.euros.2023.01.013 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

** Gnant, M; Singer, CF; Rinnerthaler, G; Pfeiler, G; Egle, D; Balic, M; Bartsch, R Position paper on CDK4/6 inhibitors in early breast cancer
MEMO-MAG EUR MED ONC. 2023; Doi: 10.1007/s12254-023-00878-1
Web of Science FullText FullText_MUG

 

** Gold, D; Nicolay, L; Avian, A; Greimel, E; Balic, M; Pristauz-Telsnigg, G; Tamussino, K; Trutnovsky, G Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial.
Maturitas. 2023; 167: 1-7. Doi: 10.1016/j.maturitas.2022.08.013
Web of Science PubMed FullText FullText_MUG

 

** Juracek, J; Madrzyk, M; Trachtova, K; Ruckova, M; Bohosova, J; Barth, DA; Pichler, M; Stanik, M; Slaby, ONDREJ Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome
CANCER GENOM PROTEOM. 2023; 20(3): 308-316. Doi: 10.21873/cgp.20383
Web of Science PubMed FullText FullText_MUG

 

** Karner, C; Anders, I; Vejzovic, D; Szkandera, J; Scheipl, S; Deutsch, AJA; Weiss, L; Vierlinger, K; Kolb, D; Kühberger, S; Heitzer, E; Habisch, H; Zhang, F; Madl, T; Reininger-Gutmann, B; Liegl-Atzwanger, B; Rinner, B Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines.
J Transl Med. 2023; 21(1): 54 Doi: 10.1186/s12967-022-03843-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Koschmieder, S; Isfort, S; Wolf, D; Heidel, FH; Hochhaus, A; Schafhausen, P; Griesshammer, M; Wolleschak, D; Platzbecker, U; Dohner, K; Jost, PJ; Parmentier, S; Schaich, M; von Bubnoff, N; Stegelmann, F; Maurer, A; Crysandt, M; Gezer, D; Kortmann, M; Franklin, J; Frank, J; Hellmich, M; Brummendorf, TH Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group
ANN HEMATOL. 2023; Doi: 10.1007/s00277-022-05080-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lindenmann, J; Fediuk, M; Fink-Neuboeck, N; Mykoliuk, I; Taucher, E; Pichler, M; Smolle, J; Smolle-Juettner, FM The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung Cancer.
Cells. 2023; 12(3): Doi: 10.3390/cells12030480 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lindner, AK; Pichler, M; Maier, S; Ulmer, H; Gorreri, T; Luger, AK; Barth, DA; Seeber, A; Kocher, F; Pichler, R Optimization of postoperative surveillance protocols in upper tract urothelial cancer: A retrospective cohort study.
Front Oncol. 2023; 13:1143030 Doi: 10.3389/fonc.2023.1143030 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moujalled, DM; Brown, FC; Chua, CC; Dengler, MA; Pomilio, G; Anstee, NS; Litalien, V; Thompson, E; Morley, T; MacRaild, S; Tiong, IS; Morris, R; Dun, K; Zordan, A; Shah, J; Banquet, S; Halilovic, E; Morris, E; Herold, MJ; Lessene, G; Adams, JM; Huang, DCS; Roberts, AW; Blombery, P; Wei, AH Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.
Blood. 2023; 141(6):634-644 Doi: 10.1182/blood.2022016090
Web of Science PubMed FullText FullText_MUG

 

** Pichler, R; Siska, PJ; Tymoszuk, P; Martowicz, A; Untergasser, G; Mayr, R; Weber, F; Seeber, A; Kocher, F; Barth, DA; Pichler, M; Thurnher, M A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma.
Front Immunol. 2023; 14:1095195 Doi: 10.3389/fimmu.2023.1095195 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Rassner, M; Waldeck, S; Follo, M; Jilg, S; Philipp, U; Jolic, M; Wehrle, J; Jost, PJ; Peschel, C; Illert, AL; Duyster, J; Scherer, F; von, Bubnoff, N Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST).
Int J Mol Sci. 2023; 24(6): Doi: 10.3390/ijms24065411 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Kienzl, M; Rittchen, S; Roula, D; Eberle, J; Sarif, Z; Pichler, M; Hoefler, G; Heinemann, A Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro
BIOLOGY-BASEL. 2023; 12(5): 706 Doi: 10.3390/biology12050706
Web of Science PubMed FullText FullText_MUG

 

** Rothermundt, C; Andreou, D; Blay, JY; Brodowicz, T; Desar, IME; Dileo, P; Gelderblom, H; Haas, R; Jakob, J; Jones, RL; Judson, I; Kunz, WG; Liegl-Atzwanger, B; Lindner, LH; Messiou, C; Miah, AB; Reichardt, P; Szkandera, J; van, der, Graaf, WTA; van, Houdt, WJ; Wardelmann, E; Hofer, S, , Writing, committee, on, behalf, of, CSSS, panellists Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022.
Eur J Cancer. 2023; 180:158-179 Doi: 10.1016/j.ejca.2022.11.008
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Helmberg, W; Matzhold, EM; Barth, DA; Sareban, N; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M Impact of allogeneic red blood cell transfusion on prognosis in soft tissue sarcoma patients. A single-centre study.
Cancer Med. 2023; 12(2):1237-1246 Doi: 10.1002/cam4.4989 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Kogler, A; Andreou, D; Scheipl, S; Bergovec, M; Castellani, C; Till, H; Benesch, M; Posch, F; Szkandera, J; Smolle-Jüttner, FM; Leithner, A Prognostic Impact of Pulmonary Metastasectomy in Bone Sarcoma Patients: A Retrospective, Single-Centre Study.
Cancers (Basel). 2023; 15(6): 1733 Doi: 10.3390/cancers15061733 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31 Doi: 10.1016/j.clgc.2022.10.005
Web of Science PubMed FullText FullText_MUG

 

** Untergasser, A; Hellemans, J; Pfaffl, MW; Ruijter, JM; van, den, Hoff, MJB; Dragomir, MP; Adamoski, D; Dias, SMG; Reis, RM; Ferracin, M; Dias-Neto, E; Marsh, I; Kubista, M; Fabbri, M; Goel, A; Slabý, O; Knutsen, E; Chen, B; Negrini, M; Mimori, K; Pichler, M; Papatriantafyllou, M; Anfossi, S; Schmittgen, TD; Huggett, J; Bustin, S; Vandesompele, J; Calin, GA, , HEROIC, (tHe, initiativE, gRoup, On, qRT, dIsClosure), Consortium, , HEROIC, (tHe, initiativE, gRoup, On, qRT, dIsClosure), Consortium Disclosing quantitative RT-PCR raw data during manuscript submission: a call for action.
Mol Oncol. 2023; Doi: 10.1002/1878-0261.13418 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Short report/Letter

** Buchacher, L; Richtig, G; Dernoscheg, M; Richtig, E; Koch, L Permanent dose reduction due to adverse reactions does not decrease efficacy of BRAF/MEK inhibition in metastatic melanoma.
J Eur Acad Dermatol Venereol. 2023; Doi: 10.1111/jdv.18871
Web of Science PubMed FullText FullText_MUG

 

** Dill, V; Wagner, CV; Keller, EC; Fernandez-Hernandez, FJ; Shoumariyeh, K; Odinius, TO; Buschhorn, L; Hauch, RT; Suren, C; Hecker, JS; Herhaus, P; Sandherr, M; Schmidt, B; Slotta-Huspenina, J; Bassermann, F; Höckendorf, U; Jilg, S; Branca, C; Vosberg, S; Jost, PJ Elevated RIPK3 correlates with disease burden in myelofibrosis.
Blood Adv. 2023; 7(7):1219-1224 Doi: 10.1182/bloodadvances.2021006838 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Review

** Lipp, RW Theranostics in prostate cancer
MEMO-MAG EUR MED ONC. 2023; Doi: 10.1007/s12254-022-00857-y
Web of Science FullText FullText_MUG

 

** Suppan, C; Balic, M Current standards and future outlooks in metastatic Her2-positive breast cancer
BREAST CARE. 2023; Doi: 10.1159/000528756 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Editorial

** Gerger, A Colorectal cancer special, part 1
MEMO-MAG EUR MED ONC. 2023; 16(1): 2-2. Doi: 10.1007/s12254-022-00866-x
Web of Science FullText FullText_MUG

 

© Med Uni GrazImprint